AAV2/4-RS1 gene therapy in the retinoschisin knockout mouse model of X-linked retinoschisis

Abstract excerpt

OBJECTIVE: To evaluate efficacy of a novel adeno-associated virus (AAV) vector, AAV2/4-RS1, for retinal rescue in the retinoschisin knockout (Rs1-KO) mouse model of X-linked retinoschisis (XLRS). Brinzolamide (Azopt®), a carbonic anhydrase inhibitor, was tested for its ability to potentiate the effects of AAV2/4-RS1. METHODS: AAV2/4-RS1 with a cytomegalovirus (CMV) promoter (2x1012 viral genomes/mL) was delivered...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neuroscience and Neural Engineering
• Share to Retinal and Macular Surgery
• Share to Retinal Development and Disorders